Loading…

Vericel Corporation was awarded a ten-year contract valued at up to $197 million by BARDA for procurement of NexoBrid, establishment of a Vendor Managed Inventory system, design of a U.S.-based manufacturing facility, and development of a next-generation formulation and blast trauma indication.
“Vericel Corporation has been awarded a ten-year contract valued at up to $197 million by the U.S. Biomedical Advanced Research and Development Authority (BARDA) for the procurement of NexoBrid.”barchart.com
Summarized from public sources; check the original articles before acting on it.